Prot# C-1808: An Open-Label, Multicenter Extension Study to Evaluate the Safety, Tolerability and Efficacy of Natalizumab in Subjects with Multiple Sclerosis Who Have Completed Studies C-1801, C-1802, or C-1803

Project: Research project

Project Details

StatusFinished
Effective start/end date9/15/044/2/07

Funding

  • Parexel (C-1808)
  • Biogen Inc. (C-1808)